Non-invasive diagnosis of nonalcoholic fatty liver and nonalcoholic steatohepatitis.
about
Nonalcoholic fatty liver disease: a comprehensive review of a growing epidemicNon-invasive Testing for NASH and NASH with Advanced Fibrosis: Are We There Yet?Noninvasive biomarkers in non-alcoholic fatty liver disease: current status and a glimpse of the future.Nonalcoholic fatty liver disease: updates in noninvasive diagnosis and correlation with cardiovascular disease.Molecular pathways in non-alcoholic fatty liver disease.The relevance of liver histology to predicting clinically meaningful outcomes in nonalcoholic steatohepatitis.Strategies, models and biomarkers in experimental non-alcoholic fatty liver disease researchThe BARD score and the NAFLD fibrosis score in the assessment of advanced liver fibrosis in nonalcoholic fatty liver diseaseElevated serum CK18 levels in chronic hepatitis C patients are associated with advanced fibrosis but not steatosis.Epidemiology and Natural History of NAFLD.Clinical approaches to non-alcoholic fatty liver diseaseNon-alcoholic fatty liver disease: non-invasive investigation and risk stratification.Republished: Non-alcoholic fatty liver disease: non-invasive investigation and risk stratification.Elevated transaminase levels among overweight adolescents in eastern China.Assessment of treatment response in non-alcoholic steatohepatitis using advanced magnetic resonance imaging.Protective effect of boswellic acids versus pioglitazone in a rat model of diet-induced non-alcoholic fatty liver disease: influence on insulin resistance and energy expenditure.HCV genotype 3 and squamous cell carcinoma antigen (SCCA)-IgM are independently associated with histological features of NASH in HCV-infected patients.Plasma cathepsin D correlates with histological classifications of fatty liver disease in adults and responds to intervention.Noninvasive markers: a double-edged sword that stratifies nonalcoholic steatohepatitis.Serum cytokeratin-18 fragment levels are useful biomarkers for nonalcoholic steatohepatitis in children.Fatty acids in non-alcoholic steatohepatitis: Focus on pentadecanoic acid.Using proteomics to discover novel biomarkers for fatty liver development and response to CB1R antagonist treatment in an obese mouse model.Non-alcoholic Fatty Liver Disease in Morbidly Obese Individuals Undergoing Bariatric Surgery: Prevalence and Effect of the Pre-Bariatric Very Low Calorie Diet.Erythrocyte antioxidant defenses as a potential biomarker of liver mitochondrial status in different oxidative conditions.Natural course of nonalcoholic fatty liver disease in southern China: a prospective cohort study.A novel murine model for non-alcoholic steatohepatitis developed by combination of a high-fat diet and oxidized low-density lipoprotein.
P2860
Q24563381-3A6A08BF-2EF1-4244-971B-02302DF51728Q30382278-5F00CFE3-550E-4751-BEFC-3584FE698314Q30432576-340BCFF7-9140-4126-BA14-075183DBC8A9Q30435948-E5AE68D4-5D0C-4537-8B50-95B19CFCEFE5Q33890230-A2045E6A-7B3B-498C-9182-FCDB54FA67A0Q34252404-D170BCD3-E7A9-45D5-B8B0-89C67017A03DQ36129673-0F5B14C3-906D-4439-A1D0-D54B43277D8CQ36577670-10D631B9-B8BC-483F-BBC7-6E786C3D21ECQ36967102-5C816EB5-E401-43B1-94FB-79FFBDE76A6FQ37041241-5267D93F-3558-4B21-A2FB-877D183D8576Q37596187-4C6C4F8E-D108-4B05-8B24-98DB4452142CQ38128548-10BFCF9C-BDFE-4B9D-8CB3-48DE47DAC617Q38204970-D84F24B6-C50A-4BE8-A0FE-0CDA16E9EF7AQ39620785-4BC0A70F-C92E-41B6-9773-AFE148ECE2C7Q40367115-D729CF3F-6CB2-49B7-B86D-D204F5C9BFC9Q41362148-291DEC20-238C-4CBB-B581-AB33D4C15B30Q41528078-4FA14019-27DD-4195-9417-529B6E920774Q41927137-3EEFDFE5-3E7F-4B6D-898E-76CE6562C626Q43073218-57FE79D9-7385-4F7E-8FC4-9FE061E1E2ABQ45951593-D325D441-A844-4E78-991E-F80495B50537Q47150578-5D613F2F-3C0C-453A-85B3-4F0D7A818FE7Q48018603-11C0CE35-5022-4931-8A70-D7AFAE2957C6Q48370723-4277612B-7669-4B6D-A7AA-4D496E018F64Q51173989-411E5BDA-ECEF-444A-A292-12AA47D377C0Q51179884-AD0DC2AF-0610-418D-9981-5B734B57A9A2Q54340432-6180DF61-84F6-4CBD-8117-07CA3655526F
P2860
Non-invasive diagnosis of nonalcoholic fatty liver and nonalcoholic steatohepatitis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Non-invasive diagnosis of nonalcoholic fatty liver and nonalcoholic steatohepatitis.
@en
Non-invasive diagnosis of nonalcoholic fatty liver and nonalcoholic steatohepatitis.
@nl
type
label
Non-invasive diagnosis of nonalcoholic fatty liver and nonalcoholic steatohepatitis.
@en
Non-invasive diagnosis of nonalcoholic fatty liver and nonalcoholic steatohepatitis.
@nl
prefLabel
Non-invasive diagnosis of nonalcoholic fatty liver and nonalcoholic steatohepatitis.
@en
Non-invasive diagnosis of nonalcoholic fatty liver and nonalcoholic steatohepatitis.
@nl
P2860
P1476
Non-invasive diagnosis of nonalcoholic fatty liver and nonalcoholic steatohepatitis.
@en
P2093
Ariel E Feldstein
Leon A Adams
P2860
P356
10.1111/J.1751-2980.2010.00471.X
P577
2011-02-01T00:00:00Z